Drift of tetM determinant in urogenital microbiocenosis containing mycoplasmas during treatment with a tetracycline antibiotic

Bulletin of Experimental Biology and Medicine

Volumn 134, Issue 1, 2002, Pages 60-63

  Taraskina, A E ^a   Savicheva, A M ^a   Akopian, T A ^b   Soroka, A E ^b   Momynaliev, K T ^b   Govorun, V M ^b  

^a D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Allele polymorphism; Antibiotic resistance; Mycoplasma hominis; tetM determinant; Ureaplasma urealyticum

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; TETRACYCLINE; TETRACYCLINE RESISTANCE PROTEIN M; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG SCREENING; FEMALE; GENE TRANSFER; GENETIC DRIFT; GENETIC POLYMORPHISM; HUMAN; MOLLICUTES; MOSAICISM; MYCOPLASMA; MYCOPLASMA HOMINIS; NONHUMAN; TRANSPOSON; UREAPLASMA UREALYTICUM; UROGENITAL TRACT INFECTION; VAGINITIS;

ADOLESCENT; ADULT; ALLELES; ANTI-BACTERIAL AGENTS; DNA TRANSPOSABLE ELEMENTS; DOXYCYCLINE; DRUG RESISTANCE; FEMALE; HUMANS; MIDDLE AGED; MYCOPLASMA; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; POLYMORPHISM, GENETIC; TIME FACTORS; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM; UROGENITAL SYSTEM;

BACTERIA (MICROORGANISMS); MOLLICUTES; MYCOPLASMA; MYCOPLASMA HOMINIS; MYCOPLASMATALES; POSIBACTERIA; TRANSPOSONS; UREAPLASMA; UREAPLASMA UREALYTICUM;

EID: 0036665010     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020664807029     Document Type: Article

References (14)

1. N. N. Zakharevich, L. N. Novikova, E. A. Mikhnina, and A. E. Taraskina, Zh. Akush. Zhensk. Bolezn., No. 2, 30-34 (2001).
2. C. Bebear, B. De Barbeyrac, C. M. Bebear, et al., Wien Klin. Wochenschr., 109, 594-599 (1997).
3. G. Christiansen, L. T. Jensen, T. Boesen, et al., Ibid., 557-561.
4. M. C. Cumming and W. M. McCormack, J. Antimicrob. Chemother., 34, No. 12, 2297-2299 (1990).
5. R. Huang, D. M. Gascoyne-Binzi, P. M. Hawkey, et al., Ibid., 40, No. 4, 561-565 (1997).
6. Manual of Clinical Microbiology, Ed. A. Balou, Washington (1991).
7. K. B. Mullis and F. Faloora, Methods Enzymol., 155, 335-350 (1987).
8. M. R. Oggioni, C. G. Dowson, J. M. Smith, et al., Plasmid, 35, No. 3, 156-163 (1996).
9. C. Poyart, J. Celli, and P. Triew-Cuot, J. Antimicrob. Chemother., 39, No. 2, 500-506 (1995).
10. S. Razin, D. Yogev, and Y. Naot, Microbiol. Mol. Biol. Rev., 62, No. 4, 1094-1156 (1998).
11. L. B. Rice, J. Antimicrob. Chemother., 42, No. 8, 1871-1877 (1998).
12. M. C. Roberts and G. E. Kenny, J. Bacteriol., 169, No. 8, 3836-3839 (1987).
13. M. C. Roberts, Antimicrob. Agents Chemother., 34, No. 3, 476-478 (1990).
14. F. Sanger, S. Nicklen, and A. R. Coulson, Proc. Natl. Acad. Sci. USA, 74, 5463-5467 (1977).